HIGHLIGHTS
- who: Jieyi Wang and colleagues from the Cuore, Italy University of Virginia have published the paper: Commentary: Effect of fecal microbiota transplantation on non-alcoholic fatty liver disease: A randomized clinical trial, in the Journal: (JOURNAL)
- how: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
- future: FMT treatment may be an effective supplement to NAFLD management but more research is needed to identify its maximum validity.
SUMMARY
Based on the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.